Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Why WeRide Stock Soared Higher This Weekfool.com
Via The Motley Fool · May 30, 2025
Silver’s Quiet Voice Is Still The Loudestcontent/com
The markets are ending the month without a bang. Barely making any noise at all. Only silver’s sign becomes louder each hour.
Via Talk Markets · May 30, 2025
Why California Gas Prices Are The Highest In Americatalkmarkets.com
As of mid-May 2025, the average gasoline price in California is $4.85 per gallon, far above the national average of $3.26.
Via Talk Markets · May 30, 2025
US Listed Chinese Stocks Drop After Trump Renews Trade Tensionsbenzinga.com
US-listed Chinese stocks, led by Alibaba, PDD, and Baidu, declined after Trump's accusation of China breaking tariff deal. NIO and XPeng also fell.
Via Benzinga · May 30, 2025
Golden Eagle Strategies Plans New ETF Targeting High-Growth Stocks During Tech Reboundbenzinga.com
Golden Eagle Strategies LLC files with SEC for a new ETF focused on high-growth companies, set to debut in mid-August 2025 with an expense ratio of 0.85%.
Via Benzinga · May 30, 2025
Canada’s Q1 GDP Expands By 2.2%, Driven By Exports Spike Ahead Of Potential U.S. Tariffstalkmarkets.com
GDP growth beat the Bank of Canada’s forecast, but momentum heading into Q2 appears limited.
Via Talk Markets · May 30, 2025
The Biggest Banking Shakeup In Decades Is Weeks Awaytalkmarkets.com
The banking industry is about to be upended.
Via Talk Markets · May 30, 2025
Just How Bad Is Uncle Sam's Interest Problem?talkmarkets.com
The U.S. government has an interest problem. It's really bad.
Via Talk Markets · May 30, 2025
What A Bond Rally Would Do For Techtalkmarkets.com
One of the reasons why the Fed has been irresponsibly late in restarting the rate cuts is because they have been concerned about tariffs leading to inflation.
Via Talk Markets · May 30, 2025
Why Trump Media Stock Crashed This Weekfool.com
Via The Motley Fool · May 30, 2025
Bitcoin, Ethereum, XRP, Dogecoin Can't Catch A Break As Traders See 'Sellers In Control'benzinga.com
Cryptocurrency markets are down on Friday, with continued uncertainty over the future of tariffs depressing risk assets.
Via Benzinga · May 30, 2025
Why Abercrombie & Fitch Stock Is Soaring This Weekfool.com
Via The Motley Fool · May 30, 2025
Netflix Stock Could Climb Another 25% Thanks To Second-Half 'Content Bonanza,' Says Bank Of Americabenzinga.com
Bank of America sees more upside for Netflix (NFLX) despite record highs. Strong ad momentum, content slate, subscriber growth support bullish call.
Via Benzinga · May 30, 2025
GAP Flags Over $100 Million Tariff Burden Outside Guidance, Near-Term Stock Pressure Likely: Analystbenzinga.com
Gap stock drops 18% as analyst flags tariff headwinds but sees FY26 recovery through ‘mitigatory levers' and pricing flexibility.
Via Benzinga · May 30, 2025
Forecasting The Future: 15 Analyst Projections For Hyatt Hotelsbenzinga.com
Via Benzinga · May 30, 2025
ServiceTitan Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)benzinga.com
Via Benzinga · May 30, 2025
17 Analysts Assess ConocoPhillips: What You Need To Knowbenzinga.com
Via Benzinga · May 30, 2025
Stock Of The Day: Is Lyft About To Breakdown?benzinga.com
Lyft chart shows how levels that were support can become resistance. It also shows resistance can become support.
Via Benzinga · May 30, 2025
Why Summit Therapeutics Plunged Todayfool.com
Via The Motley Fool · May 30, 2025
Google’s Shares Dip As Company Faces Digital Tax Threat, Antitrust Rulingtalkmarkets.com
Google stock fell to $170.68 as the company confronts a potential 10% digital services tax.
Via Talk Markets · May 30, 2025
Ulta Beauty's Glow-Up: Retailer Beats Street, Raises Outlookbenzinga.com
Ulta Beauty's comp sales grew 2.9% year-on-year to $2,848 million, beating Street expectations of $2,794 million.
Via Benzinga · May 30, 2025
Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%benzinga.com
Pfizer's BRAFTOVI combo cut death risk by 51% and more than doubled survival in BRAF-mutant colorectal cancer in a Phase 3 trial.
Via Benzinga · May 30, 2025
Foot Locker To Rebound Under Dick's? This Analyst Says It Couldbenzinga.com
Analyst Cristina Fernandez maintains Foot Locker (FL) with Market Perform rating and $24 price target following Q1 results, noting soft comp and sales due to store closures and FX.
Via Benzinga · May 30, 2025
Synopsys Halts China Sales After US Cracks Down On Chip Design Exportsbenzinga.com
Synopsys stops services in China due to US export restrictions. Products affected include semiconductor design software and chemicals.
Via Benzinga · May 30, 2025
Top S&P500 movers in Friday's sessionchartmill.com
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · May 30, 2025